<DOC>
	<DOCNO>NCT00201422</DOCNO>
	<brief_summary>To evaluate therapeutic effectiveness H. pylori eradication stage IE &amp; IIE-1 primary low-grade B cell lymphoma MALT stomach</brief_summary>
	<brief_title>Eradication Helicobacter Pylori Management Stage IE &amp; IIE-1 Primary Low-grade B Cell Lymphoma MALToma</brief_title>
	<detailed_description>To investigate prevalence H. pylori infection patient early stage primary low-grade B cell lymphoma MALT stomach Taiwan . -To evaluate therapeutic effectiveness H. pylori eradication stage IE &amp; IIE-1 primary low-grade B cell lymphoma MALT stomach . To evaluate efficacy Helicobacter pylorus eradication therapy respect objective regression rate time disease progression primary low-grade gastric MALToma . To estimate difference therapeutic efficacy relate different stage disease , eg . stage IE v.s . stage IIE-1 . To identify cause treatment failure , stage tumor , presence large cell component , and/or persistent , reactivation reinfection H. pylorus etc .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , B-Cell , Marginal Zone</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>The patient must histologically confirm primary lowgrade Bcell lymphoma MALT stomach include follow type : diffuse small lymphocytic , diffuse small cleave , diffuse mixed small large cell type Working Formulation ( Harris NL et al . 1994 ) ( 20 ) . The diagnosis primary gastric lymphoma must fulfill criterion Dawson : 1 . No enlargement peripheral mediastinal lymph node ; 2 . Peripheral blood smear reveal leukemic lymphomatous abnormality ; 3 . Predominant alimentary tract lesion adenopathy correspond accept lymphatic drainage route ; 4 . No involvement liver spleen except extension contiguous disease . The monoclonality Bcell must confirm either immunohisto chemistry ( lightchain restriction ) molecular technique ( IgH rearrangement ) . The patient must prior chemotherapy radiotherapy his/her gastric MALToma . Patients must evaluable disease endoscopy nodal status compute tomography . Endoscopic ultrasonography ( EUS ) * optional reference . H. pylori infection evaluate follow test : histology , rapid urease test ( CLOtest ) , serology C13urea breath test ( UBT ) bacterial culture* optional reference . The following consider H. pylori infection : least two follow 3 test show positive result , rapid urease test ( CLOtest ) , histology serology . For C13urea breath test , rapid urease test histology examine H. pylorus , examination must perform least 4 week apart late antibiotic nonsteroid antiinflammatory drug ingestion . Patients must either stage IE IIE1 disease , accord adaptation Ann Abor stag system modify Musshoff primary extranodal lymphoma . Stage IE : lymphoma confine gastric wall without lymph node involvement . Stage IIE : localize involvement one GI site ( ) one side diaphragm lymph node infiltration , depth lymphoma infiltration gut wall . Stage IIE1 : infiltration adjacent lymph node . Patient must sign informed consent . Patients extensive gastrointestinal tract involvement eligible . Patients previous history extranodal lymphoma eligible . Patients disease beyond stage IIE2 : infiltration regional lymph node , e.g . paraaortic , renal hilar , retroperitoneal , mesenteric , lymph node gastrosplenic ligment hepatoduodenal ligment eligible . Patients history allergic reaction Amoxicillin Erythromycin /Clarithromycin eligible . Patients whose cardiopulmonary status allow him/her repeat endoscopy eligible . Patients prior surgery , chemo radiotherapy primary gastric lymphoma eligible . Patients previous antiH . pylori therapy eligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>MALT lymphoma</keyword>
	<keyword>diffuse large B-cell lymphoma ,</keyword>
	<keyword>stomach</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>antibiotic therapy</keyword>
</DOC>